Evidence map›Paper›PMID 40011582›Full record

ArticleNature biomedical engineering2025

Radioprotection of healthy tissue via nanoparticle-delivered mRNA encoding for a damage-suppressor protein found in tardigrades.

Ameya R Kirtane, Jianling Bi, Netra U Rajesh, Chaoyang Tang, Miguel Jimenez, Emily Witt, Megan K McGovern, Arielle B Cafi, Samual J Hatfield, Lauren Rosenstock and 15 more

Abstract read
In one paragraph

Article in Nature biomedical engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Ameya R Kirtane *Division of Gastroenterology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Jianling Bi *Department of Radiation Oncology, University of Iowa, Iowa City, IA, USA.
Netra U RajeshDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-0277-6120
Chaoyang TangDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
Miguel JimenezDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-4211-1852
Emily WittDepartment of Radiation Oncology, University of Iowa, Iowa City, IA, USA.
Megan K McGovernDepartment of Radiation Oncology, University of Iowa, Iowa City, IA, USA.
Arielle B CafiDepartment of Radiation Oncology, University of Iowa, Iowa City, IA, USA.
Samual J HatfieldDepartment of Radiation Oncology, University of Iowa, Iowa City, IA, USA.
Lauren RosenstockDepartment of Radiation Oncology, University of Iowa, Iowa City, IA, USA.
Sarah L BeckerDivision of Gastroenterology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Nicole MachadoDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-8168-3493
Veena VenkatachalamDepartment of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Dylan FreitasDivision of Gastroenterology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Xisha HuangDivision of Gastroenterology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Alvin ChanDivision of Gastroenterology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-1041-3891
Aaron LopesDivision of Gastroenterology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Hyunjoon KimDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
Nayoon KimDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
Joy E CollinsDivision of Gastroenterology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Michelle E HowardDepartment of Radiation Oncology, University of Iowa, Iowa City, IA, USA.
Srija ManchkantiCarver College of Medicine, University of Iowa, Iowa City, IA, USA.
Theodore S HongDepartment of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0001-8481-6581
James D Byrne *Department of Radiation Oncology, University of Iowa, Iowa City, IA, USA. james-byrne@uiowa.edu.ORCID http://orcid.org/0000-0002-6436-2866
Giovanni Traverso *Division of Gastroenterology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. cgt20@mit.edu.ORCID http://orcid.org/0000-0001-7851-4077

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Jon C.D. Houtman · 2000 to 2026
$70.0M
CTSA K12 Program at The University of IowaK12TR004382 · NCATS · UNIVERSITY OF IOWA · PI ALEXANDER G BASSUK, Polly J Ferguson · 2023 to 2026
$3.0M
Novel extremophile-inspired radioprotectantsDP2CA301081 · NCI · UNIVERSITY OF IOWA · PI BYRNE, JAMES DONALD · 2024 to 2024
$1.4M
Exploiting Carbon Monoxide Biofoams to Radio-Sensitize Rectal Cancer Cells While Protecting Normal BowelK08CA276908 · NCI · UNIVERSITY OF IOWA · PI James Donald Byrne · 2023 to 2026
$1.0M
NCATS NIH HHS K12 TR004382NCI NIH HHS DP2 CA301081NCI NIH HHS K08 CA276908NCI NIH HHS P30 CA086862
6 · The paper itself

Abstract

Patients undergoing radiation therapy experience debilitating side effects because of toxicity arising from radiation-induced DNA strand breaks in normal peritumoural cells. Here, inspired by the ability of tardigrades to resist extreme radiation through the expression of a damage-suppressor protein that binds to DNA and reduces strand breaks, we show that the local and transient expression of the protein can reduce radiation-induced DNA damage in oral and rectal epithelial tissues (which are commonly affected during radiotherapy for head-and-neck and prostate cancers, respectively). We used ionizable lipid nanoparticles supplemented with biodegradable cationic polymers to enhance the transfection efficiency and delivery of messenger RNA encoding the damage-suppressor protein into buccal and rectal tissues. In mice with orthotopic oral cancer, messenger RNA-based radioprotection of normal tissue preserved the efficacy of radiation therapy. The strategy may be broadly applicable to the protection of healthy tissue from DNA-damaging agents.

Indexed as

NanoparticlesRadiation-Protective AgentsRNA, MessengerTardigradaAnimalsDNA DamageHumansMaleMiceRadiation-Protective AgentsRNA, Messenger

Identifiers

PMID40011582
PMCPMC12919043

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.